1245.28.20075 Boehringer Ingelheim Investigational Site

Edmonton, Alberta

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2

Studies at this site

• Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes — Completed